"Hospital Geral de alta complexidade e referência em transplante de medula óssea."

During the past decade, Hospital Nossa Senhora das Gracas conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Nossa Senhora das Gracas" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eurofarma Laboratorios S.A." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nossa Senhora das Gracas" #1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nossa Senhora das Gracas" are "COVID-19" (3 trials), "Crohn's Disease" (3 trials), "Alzheimer Disease" (2 trials), "COVID-19 Pneumonia" (1 trials) and "Candidemia" (1 trials). Many other conditions were trialed in "Hospital Nossa Senhora das Gracas" in a lesser frequency.

Most popular intervention types in "Hospital Nossa Senhora das Gracas" are "Drug" (13 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Gantenerumab" (2 trials), "Remdesivir" (2 trials), "Ustekinumab" (2 trials) and "Ad26.COV2.S" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nossa Senhora das Gracas" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nossa Senhora das Gracas". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Nossa Senhora das Gracas, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nossa Senhora das Gracas, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".